A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.

NCT02055066 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx